Aethlon Medical Inc (AEMD.OQ)
AEMD.OQ on NASDAQ Stock Exchange Capital Market
1.24USD
9:40am EST
1.24USD
9:40am EST
Change (% chg)
$-0.01 (-0.80%)
$-0.01 (-0.80%)
Prev Close
$1.25
$1.25
Open
$1.26
$1.26
Day's High
$1.26
$1.26
Day's Low
$1.24
$1.24
Volume
3,037
3,037
Avg. Vol
41,043
41,043
52-wk High
$2.04
$2.04
52-wk Low
$0.85
$0.85
Revenue & Earnings Per Share
| Revenue* | Earnings Per Share** | ||
|---|---|---|---|
| FY 2019 | Sep | 0.00 | -0.078 |
| Jun | 0.15 | -0.065 | |
| FY 2018 | Mar '18 | 0.07 | -0.080 |
| Dec | 0.07 | -0.081 | |
| Sep | 0.00 | -0.144 | |
| Jun | 0.00 | -0.209 | |
| FY 2017 | Mar '17 | 0.00 | -0.217 |
| Dec | 0.00 | -0.152 | |
| Sep | 0.39 | -0.291 | |
| Jun | 0.00 | -0.276 | |
| FY 2016 | Mar '16 | 0.20 | -0.164 |
| Dec | 0.30 | -0.160 | |
| Sep | 0.19 | -0.161 | |
| Jun | 0.19 | -0.176 |
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars
Consensus Estimates Analysis
| # of Estimates | Mean | High | Low | 1 Year Ago | |
|---|---|---|---|---|---|
| SALES (in millions) | |||||
| Quarter Ending Mar-18 | 1 | 0.00 | 0.00 | 0.00 | -- |
| Quarter Ending Jun-19 | 1 | 0.00 | 0.00 | 0.00 | -- |
| Year Ending Mar-18 | 1 | 0.08 | 0.08 | 0.08 | -- |
| Year Ending Mar-19 | 1 | 0.20 | 0.20 | 0.20 | -- |
| Year Ending Mar-20 | 1 | 0.00 | 0.00 | 0.00 | -- |
| Earnings (per share) | |||||
| Quarter Ending Mar-18 | 1 | -0.10 | -0.10 | -0.10 | -- |
| Quarter Ending Jun-19 | 1 | -0.06 | -0.06 | -0.06 | -- |
| Year Ending Mar-18 | 1 | -0.48 | -0.48 | -0.48 | -- |
| Year Ending Mar-19 | 1 | -0.28 | -0.28 | -0.28 | -0.32 |
| Year Ending Mar-20 | 1 | -0.25 | -0.25 | -0.25 | -- |
Sales and Profit Figures in US Dollar (USD);
Valuation Ratios
| Company | industry | sector | ||
|---|---|---|---|---|
| P/E Ratio (TTM) | -- | 30.69 | 30.88 | |
| P/E High - Last 5 Yrs. | -- | 39.16 | 46.69 | |
| P/E Low - Last 5 Yrs. | -- | 23.61 | 25.78 | |
| Beta | 1.98 | 0.77 | 0.95 | |
| Price to Sales (TTM) | 87.72 | 5.95 | 21.76 | |
| Price to Book (MRQ) | 6.35 | 4.48 | 4.53 | |
| Price to Tangible Book (MRQ) | 6.47 | 7.83 | 11.76 | |
| Price to Cash Flow (TTM) | -- | 23.09 | 22.24 | |
| % Owned Institutions | -- | 0.00 | 0.00 | |
Dividends
| Company | industry | sector | ||
|---|---|---|---|---|
| Dividend Yield | -- | 1.08 | 1.60 | |
| Dividend Yield - 5 Year Avg | -- | 1.16 | 1.42 | |
| Dividend 5 Year Growth Rate | -- | 15.29 | -8.76 | |
| Payout Ratio(TTM) | -- | 30.61 | 44.03 | |
Growth Rates
| Company | industry | sector | ||
|---|---|---|---|---|
| Sales (MRQ) vs Qtr. 1 Yr. Ago | -- | 2.72 | 6.54 | |
| Sales (TTM) vs TTM 1 Yr. Ago | -- | 8.29 | 5.26 | |
| Sales - 5 Yr. Growth Rate | -34.38 | 9.55 | 7.59 | |
| EPS (MRQ) vs Qtr. 1 Yr. Ago | 45.74 | -6.09 | 22.50 | |
| EPS (TTM) vs TTM 1 Yr. Ago | 57.94 | -- | -- | |
| EPS - 5 Yr. Growth Rate | -- | 14.46 | 7.64 | |
| Capital Spending - 5 Yr. Growth Rate | -- | 5.23 | 8.38 | |
Financial Strength
| Company | industry | sector | |
|---|---|---|---|
| Quick Ratio (MRQ) | -- | 2.31 | 2.63 |
| Current Ratio (MRQ) | 4.10 | 2.99 | 3.68 |
| LT Debt to Equity (MRQ) | 0.00 | 20.53 | 9.53 |
| Total Debt to Equity (MRQ) | 21.85 | 26.54 | 13.39 |
| Interest Coverage (TTM) | -8.47 | 18.59 | 33.85 |
Profitability Ratios
| Company | industry | sector | ||
|---|---|---|---|---|
| Gross Margin (TTM) | -- | 58.51 | 50.91 | |
| Gross Margin - 5 Yr. Avg. | -- | 57.92 | 52.22 | |
| EBITD Margin (TTM) | -1,619.34 | -- | -- | |
| EBITD - 5 Yr. Avg | -581.95 | 23.57 | 16.27 | |
| Operating Margin (TTM) | -1,630.38 | 18.16 | -15.11 | |
| Operating Margin - 5 Yr. Avg. | -722.10 | 16.26 | 11.89 | |
| Pre-Tax Margin (TTM) | -1,704.31 | 17.65 | -13.67 | |
| Pre-Tax Margin - 5 Yr. Avg. | -1,006.27 | 16.21 | 12.22 | |
| Net Profit Margin (TTM) | -1,704.31 | 14.05 | -17.11 | |
| Net Profit Margin - 5 Yr. Avg. | -1,006.27 | 11.55 | 8.44 | |
| Effective Tax Rate (TTM) | -- | 19.42 | 21.73 | |
| Effective Tax Rate - 5 Yr. Avg. | -- | 27.38 | 24.41 | |
Efficiency
| Company | industry | sector | ||
|---|---|---|---|---|
| Revenue/Employee (TTM) | 49,875 | 30,726,224 | 878,349,382 | |
| Net Income/Employee (TTM) | -850,025 | 3,334,701 | 102,474,711 | |
| Receivable Turnover (TTM) | -- | 5.05 | 5.49 | |
| Inventory Turnover (TTM) | -- | 3.28 | 3.99 | |
| Asset Turnover (TTM) | 0.09 | 0.75 | 0.93 | |
Management Effectiveness
| Company | industry | sector | ||
|---|---|---|---|---|
| Return on Assets (TTM) | -158.92 | 10.26 | 11.06 | |
| Return on Assets - 5 Yr. Avg. | -341.02 | 8.99 | 11.85 | |
| Return on Investment (TTM) | -203.31 | 12.93 | 13.80 | |
| Return on Investment - 5 Yr. Avg. | -- | 11.63 | 15.17 | |
| Return on Equity (TTM) | -239.51 | 15.64 | 15.29 | |
| Return on Equity - 5 Yr. Avg. | -- | 14.19 | 16.29 | |
| 1 Year | 3 Year | 5 Year | |
|---|---|---|---|
| Sales % | -61.84 | -41.89 | -34.38 |
| EPS (TTM) % | 50.80 | -- | -- |
| Dividend % | -- | -- | -- |
Note: Units in Millions of US Dollars
Performance for Aethlon Medical Inc
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.
Institutional Holders
| % Shares Owned: | 16.67% |
| # of Holders: | 17 |
| Total Shares Held: | 2,977,498 |
| 3 Mo. Net Change: | -250,386 |
| # New Positions: | 3 |
| # Closed Positions: | 2 |
| # Increased Positions: | 5 |
| # Reduced Positions: | 5 |
| # Net Buyers: | 0 |
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.